TY  - JOUR
TI  - Chemotherapy Effectiveness in Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer after Third-Line or Later Treatment: An Overtreatment Concern in Everyday Clinical Practice
AU  - Ersoy, M.
JO  - Lokman Hekim Health Sci
PY  - 2026
VL  - 6
SP  - 458
EP  - 465
DO  - 10.14744/lhhs.2026.02303
ER  -